NEWSWORTHY

Takeda's $60 billion takeover bid rejected by Shire Group of Ireland

Business Apr 20, 2018

Takeda's $60 billion takeover bid rejected by Shire Group of Ireland

Pharmaceutical giant Takeda said Thursday it had made a takeover bid worth £42 billion ($60 billion) for Ireland's Shire Group, but that its offer was rejected. "Takeda was subsequently notified that the board of Shire had rejected its proposal. Discussions between the parties regarding a ...

World / Science & Health Sep 12, 2014

FDA approves weight-loss drug Contrave

U.S. regulators are greenlighting a new weight-loss drug called Contrave, the third in a string of approvals for anti-obesity treatments. The drug was developed by Orexigen Therapeutics Inc., based in La Jolla, California. The Food and Drug Administration said Thursday that it is approved for ...

New COO pledges to take Takeda to the top

Business / Corporate Apr 2, 2014

New COO pledges to take Takeda to the top

Christophe Weber, the new chief operating officer of Takeda Pharmaceutical Co., said Wednesday he aims to make the company the world's leading drugmaker by drawing on his more than two decades of business experience at GlaxoSmithKline. He said his ambition for Takeda is "being a ...